Simple, Non-invasive Diagnostics


Arquer Diagnostics is focused on the development and commercialisation of highly accurate minichromosome maintenance (MCM) protein based non-invasive tests for cancer diagnosis and monitoring from small amounts of body fluid.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.

MCM5 Proteins are excellent cancer biomarkers because:

  • They are robustly expressed in dividing cells and those preparing to divide
  • MCM proteins are not expressed in fully differentiated cells
  • When a mass of replicating cells, such as a bladder tumour, is present MCM positive cells are shed into the body fluids
  • MCM positive cells are not usually present in the body fluids in the absence of cancer or damage